These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 20022804

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.
    J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
    [Abstract] [Full Text] [Related]

  • 23. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry.
    Narimatsu R, Patterson BK.
    Am J Clin Pathol; 2005 May; 123(5):716-23. PubMed ID: 15981811
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M, Clad A, von Knebel Doeberitz C, Wentzensen N, Rahmsdorf J, Schaffrath F, Griesser H, Freudenberg N, von Knebel Doeberitz M.
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.
    Shen Y, Gong J, He Y, Cheng G, Okunieff P, Li X.
    J Virol Methods; 2013 Feb; 187(2):288-93. PubMed ID: 23201290
    [Abstract] [Full Text] [Related]

  • 30. Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia.
    Oliveira A, Verdasca N, Pista Â.
    J Med Virol; 2013 Jul; 85(7):1235-41. PubMed ID: 23918542
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.
    Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M.
    Cancer Cytopathol; 2013 Dec; 121(12):675-87. PubMed ID: 23881840
    [Abstract] [Full Text] [Related]

  • 33. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
    Nielsen A, Iftner T, Nørgaard M, Munk C, Junge J, Kjaer SK.
    Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY, Kim H, Park KH.
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.